ChemicalBook
English   Japanese   Germany   Korea

(S)-7-((7-溴-9-((4-甲基哌嗪-1-基)甲基)-2,3-二氢-[1,4]二噁己环并[2,3-G]喹啉-8-基)甲基)-4-乙基-4-羟基-1H-吡喃并[3,4-C]吡啶-3,8(4H,7H)-二酮

(S)-7-((7-溴-9-((4-甲基哌嗪-1-基)甲基)-2,3-二氢-[1,4]二噁己环并[2,3-G]喹啉-8-基)甲基)-4-乙基-4-羟基-1H-吡喃并[3,4-C]吡啶-3,8(4H,7H)-二酮, 173419-36-8, 结构式
(S)-7-((7-溴-9-((4-甲基哌嗪-1-基)甲基)-2,3-二氢-[1,4]二噁己环并[2,3-G]喹啉-8-基)甲基)-4-乙基-4-羟基-1H-吡喃并[3,4-C]吡啶-3,8(4H,7H)-二酮
CAS号:
173419-36-8
英文名:
(S)-7-((7-bromo-9-((4-methylpiperazin-1-yl)methyl)-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl)methyl)-4-ethyl-4-hydroxy-1H-pyrano[3,4-c]pyridine-3,8(4H,7H)-dione
英文别名:
(S)-7-((7-bromo-9-((4-methylpiperazin-1-yl)methyl)-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl)methyl)-4-ethyl-4-hydroxy-1H-pyrano[3,4-c]pyridine-3,8(4H,7H)-dione;4(S)-4-ethyl-4-hydroxy-7-[7-bromo-9-(4-methylpiperazin-1-ylmethyl)-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-ylmethyl]-4,7-dihydro-1H-pyrano[3,4-c]pyridine-3,8-dione;1H-Pyrano[3,4-c]pyridine-3,8(4H,7H)-dione, 7-[[7-bromo-2,3-dihydro-9-[(4-methyl-1-piperazinyl)methyl]-1,4-dioxino[2,3-g]quinolin-8-yl]methyl]-4-ethyl-4-hydroxy-, (4S)-
中文名:
(S)-7-((7-溴-9-((4-甲基哌嗪-1-基)甲基)-2,3-二氢-[1,4]二噁己环并[2,3-G]喹啉-8-基)甲基)-4-乙基-4-羟基-1H-吡喃并[3,4-C]吡啶-3,8(4H,7H)-二酮
中文别名:
(S)-7-((7-溴-9-((4-甲基哌嗪-1-基)甲基)-2,3-二氢-[1,4]二噁己环并[2,3-G]喹啉-8-基)甲基)-4-乙基-4-羟基-1H-吡喃并[3,4-C]吡啶-3,8(4H,7H)-二酮
CBNumber:
CB63853146
分子式:
C28H31BrN4O6
分子量:
599.47
MOL File:
173419-36-8.mol

(S)-7-((7-溴-9-((4-甲基哌嗪-1-基)甲基)-2,3-二氢-[1,4]二噁己环并[2,3-G]喹啉-8-基)甲基)-4-乙基-4-羟基-1H-吡喃并[3,4-C]吡啶-3,8(4H,7H)-二酮化学性质

沸点:
830.7±65.0 °C(Predicted)
密度:
1.59±0.1 g/cm3(Predicted)
酸度系数(pKa):
11.66±0.20(Predicted)
安全信息

(S)-7-((7-溴-9-((4-甲基哌嗪-1-基)甲基)-2,3-二氢-[1,4]二噁己环并[2,3-G]喹啉-8-基)甲基)-4-乙基-4-羟基-1H-吡喃并[3,4-C]吡啶-3,8(4H,7H)-二酮性质、用途与生产工艺

(S)-7-((7-溴-9-((4-甲基哌嗪-1-基)甲基)-2,3-二氢-[1,4]二噁己环并[2,3-G]喹啉-8-基)甲基)-4-乙基-4-羟基-1H-吡喃并[3,4-C]吡啶-3,8(4H,7H)-二酮 上下游产品信息

上游原料

下游产品


(S)-7-((7-溴-9-((4-甲基哌嗪-1-基)甲基)-2,3-二氢-[1,4]二噁己环并[2,3-G]喹啉-8-基)甲基)-4-乙基-4-羟基-1H-吡喃并[3,4-C]吡啶-3,8(4H,7H)-二酮 生产厂家

供应商联系电话电子邮件国家产品数优势度
药明览博(武汉)化学科技有限公司 022-59987777 13552403979 jia_guoqiang@wuxiapptec.com 中国 22346 58
Labnetwork lnc. +86-27-50766799 +8618062016861 contact@labnetwork.com 中国 19994 58
苏州美石生物科技有限公司 1173954148q meishipharma@126.com 中国 20035 58
 

173419-36-8, (S)-7-((7-溴-9-((4-甲基哌嗪-1-基)甲基)-2,3-二氢-[1,4]二噁己环并[2,3-G]喹啉-8-基)甲基)-4-乙基-4-羟基-1H-吡喃并[3,4-C]吡啶-3,8(4H,7H)-二酮 相关搜索:

  • C28H31BrN4O6
  • (S)-7-((7-溴-9-((4-甲基哌嗪-1-基)甲基)-2,3-二氢-[1,4]二噁己环并[2,3-G]喹啉-8-基)甲基)-4-乙基-4-羟基-1H-吡喃并[3,4-C]吡啶-3,8(4H,7H)-二酮
  • 173419-36-8
  • 1H-Pyrano[3,4-c]pyridine-3,8(4H,7H)-dione, 7-[[7-bromo-2,3-dihydro-9-[(4-methyl-1-piperazinyl)methyl]-1,4-dioxino[2,3-g]quinolin-8-yl]methyl]-4-ethyl-4-hydroxy-, (4S)-
  • 4(S)-4-ethyl-4-hydroxy-7-[7-bromo-9-(4-methylpiperazin-1-ylmethyl)-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-ylmethyl]-4,7-dihydro-1H-pyrano[3,4-c]pyridine-3,8-dione
  • (S)-7-((7-bromo-9-((4-methylpiperazin-1-yl)methyl)-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl)methyl)-4-ethyl-4-hydroxy-1H-pyrano[3,4-c]pyridine-3,8(4H,7H)-dione
Copyright 2016 © ChemicalBook. All rights reserved